Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups
- 15 February 2022
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 919, 174829
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P40OD010440)
- Chinese Academy of Sciences
- Ministry of Science and Technology of the People's Republic of China (2021ZD0203003)
- Beijing National Laboratory for Molecular Sciences (BNLMS202108)
This publication has 42 references indexed in Scilit:
- Oxidative stress induces mitochondrial dysfunction and a protective unfolded protein response in RPE cellsFree Radical Biology and Medicine, 2014
- Oxidative stress in Alzheimer’s diseaseNeuroscience Bulletin, 2014
- Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 micePsychopharmacology, 2014
- Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In VitroCellular and Molecular Neurobiology, 2013
- Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptorsNeuropharmacology, 2013
- Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicityHuman Molecular Genetics, 2012
- A Caenorhabditis elegans model of tau hyperphosphorylation: Induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tauNeurobiology of Aging, 2009
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Genome Sequence of the Nematode C. elegans : A Platform for Investigating BiologyScience, 1998
- Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.Proceedings of the National Academy of Sciences, 1995